科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/11/20 | 5,710 | 5,770 | 5,630 | 5,750 | -60 | -1% | 241,900 |
2017/11/17 | 5,720 | 5,830 | 5,700 | 5,810 | +80 | +1.4% | 215,400 |
2017/11/16 | 5,640 | 5,730 | 5,640 | 5,730 | +80 | +1.4% | 215,300 |
2017/11/15 | 5,770 | 5,770 | 5,650 | 5,650 | -130 | -2.2% | 168,900 |
2017/11/14 | 5,800 | 5,830 | 5,780 | 5,780 | -20 | -0.3% | 105,100 |
2017/11/13 | 5,840 | 5,860 | 5,770 | 5,800 | ±0 | ±0% | 167,500 |
2017/11/10 | 5,740 | 5,820 | 5,740 | 5,800 | -40 | -0.7% | 147,800 |
2017/11/09 | 5,840 | 5,940 | 5,800 | 5,840 | +10 | +0.2% | 294,100 |
2017/11/08 | 5,760 | 5,840 | 5,630 | 5,830 | -10 | -0.2% | 342,000 |
2017/11/07 | 5,720 | 5,880 | 5,690 | 5,840 | +140 | +2.5% | 220,400 |
2017/11/06 | 5,720 | 5,870 | 5,660 | 5,700 | -90 | -1.6% | 326,000 |
2017/11/02 | 5,870 | 5,880 | 5,790 | 5,790 | -30 | -0.5% | 136,800 |
2017/11/01 | 5,780 | 5,850 | 5,770 | 5,820 | +80 | +1.4% | 175,800 |
2017/10/31 | 5,680 | 5,750 | 5,670 | 5,740 | +10 | +0.2% | 130,100 |
2017/10/30 | 5,770 | 5,790 | 5,730 | 5,730 | -80 | -1.4% | 362,000 |
2017/10/27 | 5,820 | 5,830 | 5,770 | 5,810 | -20 | -0.3% | 178,600 |
2017/10/26 | 5,870 | 5,870 | 5,800 | 5,830 | -10 | -0.2% | 93,800 |
2017/10/25 | 5,920 | 5,920 | 5,830 | 5,840 | -50 | -0.8% | 109,100 |
2017/10/24 | 5,860 | 5,910 | 5,860 | 5,890 | +10 | +0.2% | 112,700 |
2017/10/23 | 5,940 | 5,940 | 5,870 | 5,880 | -30 | -0.5% | 126,200 |
2017/10/20 | 5,940 | 5,940 | 5,860 | 5,910 | -10 | -0.2% | 136,200 |
2017/10/19 | 5,950 | 5,960 | 5,890 | 5,920 | ±0 | ±0% | 133,300 |
2017/10/18 | 5,780 | 5,940 | 5,780 | 5,920 | +180 | +3.1% | 276,000 |
2017/10/17 | 5,720 | 5,740 | 5,680 | 5,740 | +20 | +0.3% | 159,700 |
2017/10/16 | 5,700 | 5,740 | 5,680 | 5,720 | +40 | +0.7% | 248,400 |
2017/10/13 | 5,680 | 5,710 | 5,640 | 5,680 | -20 | -0.4% | 192,900 |
2017/10/12 | 5,720 | 5,720 | 5,680 | 5,700 | +10 | +0.2% | 206,600 |
2017/10/11 | 5,710 | 5,750 | 5,680 | 5,690 | -10 | -0.2% | 167,600 |
2017/10/10 | 5,690 | 5,730 | 5,680 | 5,700 | ±0 | ±0% | 180,400 |
2017/10/06 | 5,680 | 5,700 | 5,660 | 5,700 | ±0 | ±0% | 129,400 |
2017/10/05 | 5,700 | 5,720 | 5,690 | 5,700 | +10 | +0.2% | 96,200 |
2017/10/04 | 5,750 | 5,760 | 5,680 | 5,690 | -60 | -1% | 123,000 |
2017/10/03 | 5,770 | 5,770 | 5,700 | 5,750 | +10 | +0.2% | 168,200 |
2017/10/02 | 5,760 | 5,780 | 5,720 | 5,740 | +20 | +0.3% | 126,500 |
2017/09/29 | 5,720 | 5,750 | 5,690 | 5,720 | -10 | -0.2% | 135,300 |
2017/09/28 | 5,810 | 5,820 | 5,710 | 5,730 | -60 | -1% | 190,200 |
2017/09/27 | 5,820 | 5,840 | 5,770 | 5,790 | -100 | -1.7% | 102,200 |
2017/09/26 | 5,800 | 5,900 | 5,800 | 5,890 | +90 | +1.6% | 127,900 |
2017/09/25 | 5,780 | 5,810 | 5,760 | 5,800 | +40 | +0.7% | 74,400 |
2017/09/22 | 5,800 | 5,810 | 5,730 | 5,760 | ±0 | ±0% | 84,600 |
2017/09/21 | 5,860 | 5,900 | 5,750 | 5,760 | -120 | -2% | 153,500 |
2017/09/20 | 5,850 | 5,900 | 5,830 | 5,880 | +50 | +0.9% | 168,300 |
2017/09/19 | 5,800 | 5,840 | 5,760 | 5,830 | +30 | +0.5% | 123,600 |
2017/09/15 | 5,800 | 5,850 | 5,790 | 5,800 | +10 | +0.2% | 178,300 |
2017/09/14 | 5,690 | 5,840 | 5,670 | 5,790 | +140 | +2.5% | 190,800 |
2017/09/13 | 5,680 | 5,720 | 5,630 | 5,650 | -80 | -1.4% | 296,500 |
2017/09/12 | 5,800 | 5,820 | 5,720 | 5,730 | -20 | -0.3% | 86,300 |
2017/09/11 | 5,730 | 5,800 | 5,710 | 5,750 | +90 | +1.6% | 114,200 |
2017/09/08 | 5,640 | 5,690 | 5,640 | 5,660 | -40 | -0.7% | 107,600 |
2017/09/07 | 5,660 | 5,770 | 5,650 | 5,700 | +30 | +0.5% | 138,000 |
1851~
1900
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム